home  |  contact  |  worldwide sites  |  novartis.com
News and Events

Current news

Archives
 
News

 

February 09, 2008

 

Back to all media releases

 

Sebivo in Bangladesh

 

Dhaka, February 9, 2008 - Sebivo was launched in Bangladesh, a densely populated country with intermediate endemicity for chronic hepatitis B (CHB).

 

With a population of 150 million, HBsAg positivity in adults in Bangladesh is approximately 7.3-7.5%.


The reported case of CHBV is also increasing through increased Health Screening which is also a reason to pull more patients under treatment.

To ensure the best possible results with the introduction of Sebivo in the Bangladesh market, Novartis implemented a crash program addressing the opportunities from February 2008 to May 2008.

 

3 Expert meetings with different Specialty KOLs

 

Expert Meeting with Hepatologist

Expert Meeting with Gastroenterologist

Expert Meeting with Medicine Specialist

 

 

"Sebivo Go To Launch" meeting for Sebivo Team

 

A full day training covers disease, product, patients, A2B model call, and key messages

Held on January 17th, 2008 prior to introducing the product  

 

 

Launch Meeting

 

 

Regional Teams in different costumes with one theme sharing their aspirations with Sebivo in Launch meeting

 

About Novartis  

Novartis is a world leader in offering medicines to protect health, treat diseases and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. Novartis is the only company with leadership positions in both patented and generic pharmaceuticals (Sandoz). We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high quality and affordable generics (Sandoz), human vaccines and leading self-medication OTC brands. Headquartered in Basel, Switzerland, Novartis Group companies employ more than 100,000 people and operate in over 140 countries around the world.

Novartis has manufacturing and marketing operations in Bangladesh since 1973 in areas of Research, Off Patent Branded Generic (Sandoz) and OTC Pharmaceuticals along with Animal Health.

 

 

###

     

Novartis (Bangladesh) Limited - Media Relations

 

Rasna Hasan

Head of Corporate Affairs and Communication

Novartis (Bangladesh) limited

House 50, Road 2A

Dhanmondi RA

Dhaka 1209

BANGLADESH

 

+880 2 8615302-8

 rasna.hasan@sandoz.com

 

The information in the media releases on these pages was factually accurate on the date of publication. These media releases remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.

 

 
 
 

 

Download

 

 Product Launch

Lucentis

Aclasta

Sebivo

Ticlon

Doloran PRT

 35 Years in the Bangladesh

 
 
Use of this website is governed by our Terms of Use and Privacy Policy © 2008 Novartis (Bangladesh) Limited